Trial in Steyr

False weight loss injections sold to beauty doctor

The Ozempic slimming injection trend brought two men to court in Steyr (Upper Austria). They are said to have sold the wrong drug to a doctor. Three women are said to have developed health problems. However, the trial was called off at short notice because the judge fell ill.

The so-called 'Ozempic' pens, with the active ingredient semaglutide, are actually used to treat diabetes, but they have recently also been used for weight loss. This caused supply problems.

Wrong active ingredient
According to the public prosecutor's office, the two defendants allegedly sold injections with insulin instead of the active ingredient semaglutide. They allegedly obtained these from a German who was not actually authorized to sell medicines.

Because three patients developed health problems, the defendants also have to answer for the charge of negligent bodily harm. If convicted, the two men face up to three years in prison.